Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,807.95
(
0.07%
)
News Focus
News Focus
Post# of 236717
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

djjazzyjeff

Send PM Follow Ignore
Followers 7
Posts 2541
Boards Moderated 0
Alias Born 03/14/2020

djjazzyjeff

Re: ombowstring post# 170410

Tuesday, 06/15/2021 12:25:50 PM

Tuesday, June 15, 2021 12:25:50 PM

Post# of 236717
I'm not sure how anecdotal evidence is better than poor trial design when anecdotal evidence is literally no trial design. The whole point of trials is because anecdotal evidence is not indicative of efficacy. It's indicative of the possibility. Yes, at one point, leronlimab had possible covid efficacy. That was proven to be a false positive.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYDY News
More CYDY News